Cato Policy Analysis No. 72 May 20, 1986

Policy Analysis

Compassion Vs Control:
FDA Investigational-Drug Regulation

by Dale H. Gieringer

Dale H. Gieringer is a writer and policy analyst affiliated with the Decisions and Ethics Center of Stanford University.


Executive Summary

"The basic problem is, I don't have as much control over what I can do to get well as I want."

--AIDS patient[1]

"I think the FDA should recognize its responsibility for the denial of lifesaving technology."

--Robert Jarvik, developer of the artificial heart[2]

Full Text of Policy Analysis No. 72 (HTML)

1986 The Cato Institute
Please send comments to webmaster